Imaxio is a biopharmaceutical company in France specializing in vaccines and genomics. They develop innovative vaccines and immunotherapies using the IMX313 technology platform, with marketed products for human leptospirosis and Wilson disease.
Phone
+33 4 37 65 55 00
Year Founded
2000
